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Summary
 Background Breast conserving surgery followed by irradiation and subsequent systematic ap-
plication of therapy has been recognized as an efﬁ cient method for the treat-
ment of early breast cancer for many years. The results of conservative treatment 
show a relatively low percentage of local relapses and good cosmetic results
 Aim The aim of the paper was to analyse the frequency and intensity of late compli-
cations after conservative treatment in breast carcinoma patients.
 Materials/Methods A group of 67 patients with stage I and II breast carcinoma, according to the TNM 
classiﬁ cation, and who underwent conservative treatment in the Lower-Silesian 
Centre for Oncology between 1995 and 2001 were included in the study. All pa-
tients underwent irradiation of the breast after conservative treatment. In 93% 
the total dose was 50Gy and in the remaining 7% the dose amounted to 46–48Gy. 
The dose was around 10Gy higher at the tumour site. Irradiation of the lymph 
nodes was applied in 25% of cases and chemotherapy was used in 40%.
  The occurrence and intensity of late complications were assessed at 3–6 month-
ly intervals. Complications included: lymphatic swelling of the ipsilateral upper 
limb, necrosis of the soft tissues, post-radiation pneumonia, lung ﬁ brosis, post-ra-
diation rib fractures, plexopathy, late skin reaction and telangiectasia. Intensity 
was assessed using our own 4 level scale.
 Results Level 2 complications were observed in 22% of the patients and Level 3 compli-
cations were seen in 6%. No Level 4 complications were observed. Lymphatic 
swelling of the ipsilateral upper limb was the most frequent complication and oc-
curred in 22% of the patients. Level 2 and Level 3 swelling was observed in 14.5%. 
Level 2 and 3 late post-radiation reactions were observed in 9% of the patients. 
Telangiectasia within the boost area was observed in 4.5% of the patients and 
outside the boost area in 9%. No local recurrence of carcinoma was observed.
 Conclusions The results of conservative treatment of breast carcinoma patients show low in-
tensiﬁ cation of complications.
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BACKGROUND
Breast conserving surgery followed by irradiation 
and subsequent systematic application of thera-
py has been recognized as an efﬁ cient method 
for the treatment of early breast cancer for many 
years. The results of conservative treatment show 
a relatively low percentage of local relapses and 
good cosmetic results [1–3]. The therapy is bur-
dened with side effects, as are others kinds of ther-
apy. Efﬁ cient therapy leads to a lengthening of 
the lives of patients, with the effect that the oc-
currence and intensiﬁ cation of late post-radiation 
complications becomes more probable.
Clinical research has shown that the probability of 
the occurrence of late post-radiation reactions de-
pends on many factors, including the level of frac-
tion dose, total applied dose, irradiated volume of 
tissues, choice of radiotherapy technique, irradia-
tion of the post-tumour site (boost), homogeneity of 
the dose in the treated area, whether or not system-
ic therapy is combined with irradiation and on the 
individual characteristics of the patient [4–8].
The results of long-term clinical research allow 
for the selection of a group with late complica-
tions resulting from breast irradiation, the most 
frequently occurring being pain, swelling and 
breast ﬁ brosis. These, however, subside with time. 
Atrophy, telangiectasias, skin and soft tissue necro-
sis also occur from time to time. Radiotherapy of 
lymph node areas may result in serious compli-
cations, such as swelling of the ipsilateral upper 
limb, post-radiation pulmonary ﬁ brosis, broken 
ribs or defects in the shoulder plexus. Such com-
plications are increasingly frequent, irreversible 
and very difﬁ cult to treat [9–11].
To assess the risk of the occurrence of these com-
plications, it is necessary to conduct long-term 
observation and monitoring of late post-radia-
tion reactions in everyday oncological treatment. 
The EORTC/RTOG (the European Organization 
for Research and Treatment of Cancer and the 
Radiation Therapy Oncology Group) has proposed 
the use of the LENT-SOMA scale to assess the occur-
rence and intensiﬁ cation of late post-radiation reac-
tions [12,13]. The scale, as presented by Fehlauer 
et al. [14], may only be used for the assessment of 
the late effects of mammary gland irradiation while 
numerous other studies have concentrated only 
on selected complications, with the result that it is 
difﬁ cult to make a full assessment of the frequen-
cy and intensity of possible failures in conservative 
therapy. Lymphatic swelling of the ipsilateral up-
per limb [7,15–17] and obtained cosmetic effects 
[6,7,11,18] were assessed most often. There have 
been few studies on the occurrence and intensity 
of signiﬁ cant post-radiation complications though 
these are necessary to fully assess the tolerance of 
selected treatment methods [15,16,19].
AIM
The aim of the study was to prospectively ana-
lyse the frequency and intensity of late complica-
tions after conservative treatment of breast can-
cer patients according to our own 4 degree scale 
of complication intensity.
MATERIALS AND METHODS
75 patients after conservative surgery and with 
histopathologically conﬁ rmed invasive breast 
carcinoma were treated with irradiation at the 
Department of Radiotherapy I, Lower Silesia Centre 
for Oncology, between 1995 and February 2001. 
Eight patients were excluded from the analysis (7 
failed to attend biannual control examinations and 
1 died following a myocardial infarction 18 months 
after completion of radiotherapy to the left breast). 
The remaining group of 67 patients was used as 
research material. The average period of observa-
tion was 49 months while the shortest and longest 
periods of observation were 30 and 82 months re-
spectively. The period of observation from the end 
of radiotherapy to the end of the observation peri-
od (in months) is presented in Table 1.
Patients with unilateral invasive breast carcinoma 
were analysed. In 31 patients, carcinoma was found 
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in the left breast and in the right breast of 36 pa-
tients. The youngest patient was 27 years of age at 
the time of surgery while the oldest was 70 years 
old. The average age was 49 years. In a group of 
30 patients, a tumourectomy was performed and 
in 37 patients (i.e. 55%) a more extensive quad-
rantectomy was performed. In tumourectomy pa-
tients, tumours were removed with a surrounding 
1cm margin of healthy tissue. In quadrantectomy 
patients, tumours were removed with a 2–3cm mar-
gin of tissue and the skin from over the tumour. 
The removal of three levels of axillary lymph nodes 
was performed either simultaneously or consecu-
tively in 95% of cases (64 patients).
In most cases, i.e. in 59 patients (88%), the tu-
mour was in the upper outer quadrant, in 4 pa-
tients (6%) it lay on the border between the 
upper quadrants and in 4 patients it was located 
in the lower quadrants. The group comprised 
patients in stages I (T1N0M0) and II (T1N1M0, 
T2N0M0 i T2N1M0) of advancement according 
to the TNM classiﬁ cation, with primary tumours 
not larger than 3 cm in diameter. 94% of the pa-
tients had T1 features.
The N1 feature – metastases to the axillary lymph 
nodes – was observed in 25% of the patients (17 
patients). The characteristics of clinical advance-
ment according to the TNM classiﬁ cation is pre-
sented in Table 2.
Ductal carcinoma was most frequently diagnosed 
in the microscopic examination of the primary 
tumour (in 84% of the patients). A medium lev-
el of malignancy (G2) was most frequent (48%) 
while low malignancy (G1) was diagnosed in 32% 
and high malignancy (G3) was diagnosed in 20% 
of the patients.
All patients after conservative surgery were irra-
diated. Radiotherapy was started, on average, 9 
weeks after surgery. The shortest period before 
radiotherapy was 3 weeks and the longest was 26 
weeks. All patients whose irradiation was started 
more than 12 weeks after the surgery were also 
treated chemically.
Photon irradiation was conducted under mega-
volt conditions, mainly 4 and 6MeV and, during 
the period from1995 to 1997, also with Co-60 at 
1.25MeV and photons at 9MeV.
In 93% of cases the whole breast was irradiated, 
up to a total dose of 50Gy, and in 7% (5 patients) 
a total dose of 46–48Gy was used. Additionally, 
the dose was boosted at the tumour site using a 
10Gy dose at 6, 9, 12 or 16MeV. Photon boost was 
used sporadically. If metastases were observed in 
more than one axillary lymph node, irradiation 
of the supraclavicular area and axilla with a total 
dose of 50Gy was applied. Radiotherapy of the 
”nod” area was used in 17 patients.
For irradiation of the breast, an isocentric tech-
nique with tangential ﬁ elds was used. The com-
mon isocentre technique was used for irradiation 
of the breast with supraclavicular and axillary 
lymph nodes. The daily fractional dose calculat-
ed at the reference point (isocentre) was 2Gy. In 
cases involving a large volume of breast tissue a 
fractional dose of 1.8Gy was used.
Patients with metastases to the axillary lymph 
nodes (pN1) and tumours larger than 1cm were 
treated by chemotherapy or hormone therapy, 
depending on receptor status. Chemotherapy 
was used in 27 patients. 25 women received CMF 
chemotherapy and 2 received AC chemotherapy. 
12 patients received CMF chemotherapy during 
radiotherapy. Usually, CMF chemotherapy was 
applied in 1–2 courses, during which all three 
CMF cytostatics were administered.
The occurrence and intensiﬁ cation of late com-
plications were assessed regularly in 3–6 month 
Duration of observation 
in months
Number
of patients
Number
of patients (%)
30–36 23 34
37–48 15 22
49–60 7 11
61–82 22 33
Table 1. Duration of observation from the end of radiotherapy 
(months).
Advancement acc. to TNM Number of patients (%)
T1N0 70
T1Nx 2
T1N1 22
T2N0 3
T2N1 3
Table 2. TNM Advancement in a group of 67 patients.
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periods. Occurrences of lymphatic swelling of 
the ipsilateral upper limb, soft tissue necrosis, 
post-radiation pneumonia, pulmonary ﬁ brosis, 
post-radiation rib fractures, plexopathy, late skin 
reactions and telangiectasia were analysed. The 
intensiﬁ cation of the above symptoms was as-
sessed according to our own 4-level scale which 
is presented in Table 3. Late post-radiation skin 
reactions were assessed using the RTOG/EORTC 
scale. The scale of telangiectasia intensiﬁ cation in 
the breast and boost area was based on the LENT 
SOMA scale, as presented in Table 4.
The frequency of the occurrence and intensiﬁ ca-
tion of lymphatic swellings were thoroughly ana-
lysed. The circumference of both upper limbs was 
measured at four levels at 6-monthly intervals.
If a circumferential difference of 2cm or more at 
corresponding levels was recorded, it was consid-
ered to be the result of a lymphatic swelling. The 
period between the end of treatment and the 
occurrence of the swelling was also assessed.
A 4-level scale based on the LENT SOMA system 
was used to determine the degree of swelling: 
Level 1: minimum swelling; a 2–3cm difference 
in limb circumference at corresponding levels;
Level 2: medium swelling; a 3–5cm difference in 
limb circumference at corresponding levels;
Level 3: intensive swelling; a difference in limb 
circumference of more than 5cm or impaired 
functioning of the limb;
Level 4: loss of limb functions.
The inﬂ uence of radiotherapy on the occur-
rence of swelling in the supraclavicular and ax-
illary lymph node areas was assessed. Statistical 
analysis was performed using the statistical 
software Statistica 6.0 PL. The Chi-square test 
was used and test values N, df, and P were de-
ﬁ ned.
Complication Level 1 Level 2 Level 3 Level 4
Necrosis of soft tissues Moderate Resection required Skin transplant required Resection within the chest 
wall required
Post-radiation pneumonia Moderate Medium Hospitalisation required Life threatened
Lung ﬁ brosis Asymptomatic (visible 
changes in chest x-ray)
Eﬀ ort dyspnoea Dyspnoea in normal activity Dyspnoea at rest
Rib fracture One rib Two or three ribs Over ﬁ ve ribs
Plexopathy Subjective symptoms Moderate objective 
symptoms
Weakened functioning Paralysis
Skin reaction acc. to 
RTOG/EORTC
Slight atrophy, colour 
changes
Spotted atrophy, moderate 
telangiectasia
Signiﬁ cant atrophy and 
telangiectasia
Ulceration
Table 3. Intensity of late complications.
Telangiectasia within the boost area <1cm2 1–4cm2 >4cm2
Telangiectasia outside the boost area <1cm2 1–4cm2 >4cm2
Table 4. Intensity of telangiectasias.
Use of lymph node radiotherapy Swelling (n – number of patients) No swelling (n – number of patients) Total
Yes 7 10 17
No 8 42 50
Total 15 52 67
Table 5. Relationship between swelling and irradiation of lymph node areas.
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RESULTS
Lymphatic swelling of the ipsilateral upper limb 
was the most frequently observed late complica-
tion. It was observed in 15 (22%) of the 67 ana-
lysed cases. The swelling occurred after an aver-
age of 16 months from the end of radiotherapy 
(ranging from immediately after therapy to 2 
years after it). Level 1 swelling was observed in 
5 patients, Level 2 in 9 and Level 3 in only one 
patient.
The inﬂ uence of irradiation on lymphatic swell-
ings of the lymph nodes of the supraclavicular 
– axillary area in the ipsilateral upper limb was 
analysed. The number of patients in groups is 
presented in Table 5. The data indicated that ir-
radiation of lymph nodes inﬂ uences the occur-
rence of swelling. It occurred more often when 
the axillary area was irradiated (7/10) than when 
it was not (8/42). The dependency is close to 
being statistically signiﬁ cant (Chi-square =3.29, 
df=1, P=0.069).
Table 6 shows an assessment of the frequency of 
late complications after conservative treatment. 
Post-radiation skin reaction was the second most 
commonly observed complication after lymphat-
ic swelling. Level 2 and 3 post-radiation skin reac-
tions occurred in 9 patients (13.5%). 3 patients 
had Level 2 post-radiation skin reactions with 
moderate telangiectasias in the skin of the breast. 
Level 3 complications occurred as skin reactions 
with intensiﬁ ed telangiectasias in the skin of the 
breast. Necrosis of the soft tissues occurred in one 
patient after irradiation of an area close to a post-
operative scar which was proving difﬁ cult to heal 
and required resection. Necrosis developed in the 
vicinity of Spence’s tail – the irradiated site of the 
tumour. Post-radiation fractures of three ribs and 
effort dyspnoea occurred in one patient.
Level 2 complications occurred in 22% of pa-
tients and Level 3 in 6%. None of the patients 
had Level 4 complications. Lymphatic swelling 
of the ipsilateral upper limb was the most fre-
quent complication. The results of the analysis 
are shown in Table 6.
Intensiﬁ cation of telangiectasia is presented in 
Table 7.
No local recurrence of carcinoma was observed 
in any of the patients.
Complication Level 1Number of patients (%)
Level 2
Number of patients (%)
Level 3
Number of patients (%)
Level 4
Number of patients (%)
Necrosis of soft tissues  0  1 (1.5)  0  0
Lung ﬁ brosis  3 (4.5)  1 (1.5)  0  0
Post-radiation pneumonia  0  0  0  0
Rib fracture  0  1 (1.5)  0  0
Plexopathy  2 (3.0)  0  0  0
Skin reaction acc. to 
RTOG/EORTC  5 (7.5)  3 (4.5)  3 (4.5)  0
Lymphatic swelling  5 (7.5)  9 (13.0)  1 (1.5)  0
Total  15 (22.5)  9 (22.0)  4 (6.0)  0
Table 6. Frequency of late complications after treatment.
Level 1
Number of patients, (%)
Level 2
Number of patients, (%)
Level 3
Number of patients, (%)
Telangiectasia within the boost area  1 (1.5)  1 (1.5)  1 (1.5)
Telangiectasia outside the boost area  0  0  6 (9.0)
Table 7. Intensity of telangiectasia.
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DISCUSSION
Conservative surgery with irradiation of the breast 
is an alternative to mastectomy, with respect to 
local control and to long-term results, which al-
lows for preservation of the organ. The purpose 
of conservative treatment is to provide, apart from 
the positive effect of breast preservation, the best 
possible local control and the lowest number of 
complications. A lot of attention has been paid to 
factors which inﬂ uence the cosmetic and unde-
sirable effects of conservative treatment. As pos-
sibilities for treating late results are limited, the 
risk of severe late complications must be kept at 
the lowest possible level.
Meric et al. examined the frequency and intensi-
ty of complications after breast conserving ther-
apy in 294 patients with an average observation 
time of 89 months. In axillary lymphadenectomy, 
the lymph nodes of the ﬁ rst and second axillary 
levels were removed. The scale of the intensiﬁ -
cation of symptoms, including the occurrence of 
lymphatic swelling, the degree of immobilisation 
of the limb, breast ﬁ brosis, axillary ﬁ brosis, soft 
tissue necrosis, post-radiation pneumonia, rib 
fracture and plexopathy were investigated in the 
study. The results show that surgical conservative 
treatment with radiotherapy resulted in Level 2 
and Level 3 late complications in only 9.9% of 
the patients. Lymphatic swellings of the ipsilat-
eral upper limb were the most frequent compli-
cations. The average time to its occurrence was 
17 months after surgical treatment. Non-patho-
logical Level 2 rib fractures (of two or three ribs) 
occurred in one patient (0.3%). In two patients 
(0.7%), neurological symptoms arose, resulting 
from injuries to the shoulder plexus, which re-
quired the use of narcotic analgesics. In one of 
these two patients, pain caused a reduction in mo-
bility of the upper limb. In two patients (0.7%), 
symptomatic post-radiation pneumonia occurred. 
Asymptomatic lung ﬁ brosis was observed in six 
patients (2%) [15].
Wazer indicated that among 9% of 234 patients 
treated with BCT, late complications such as 
swelling of the arm, post-radiation pneumonia 
and local skin reactions occurred. Symptomatic, 
i.e. post-radiation pneumonia, requiring phar-
macological intervention (corticosteroids or 
bronchodilators) was observed in 1.6% of the 
patients. No dependency between the frequen-
cy of complications and the extent of the sur-
gery, number of radiotherapy ﬁ elds or the use 
of systematic treatment was observed. However, 
the authors suggested that the frequency of the 
complication may be reduced through elimina-
tion of methotrexate during radiotherapy and 
by irradiating the smallest possible portion of 
the lungs [16].
In their study, Fowble et al. assessed complica-
tions after BCT, the most frequent of which was 
lymphatic swelling of the arm. Average and se-
vere swelling of the arm was observed in 5% of 
patients, whereas symptomatic pneumonia, rib 
fractures, pericarditis and plexopathy were ob-
served in less than 3% of the patients [19].
Chua et al. performed a retrospective assessment 
of 1158 patients who were conservatively treated 
with surgery and irradiated in the I and II stage of 
breast cancer. It was observed that by adding the 
node area to breast irradiation a signiﬁ cantly in-
creased occurrence of symptomatic post-radiation 
pneumonia occurred. This symptom was observed 
in 4% of the patients whose node areas were ir-
radiated, as compared to 1% of patients whose 
nodes were not irradiated (p<0.001) [20].
Markiewicz et al. examined a group of 1053 pa-
tients and observed that pneumonia and rib 
fractures were rare complications. The use of 
chemotherapy does not signiﬁ cantly increase the 
occurrence of symptomatic pneumonia which was 
noted in 1.3% of the patients treated with chem-
otherapy and in 0.3% of the patients who were 
not. The frequency of symptomatic post-radia-
tion pneumonia in patients who received chem-
ical treatment and whose nodes were irradiated 
was very low, 1.4% [7].
No cases of post-radiation pneumonia were ob-
served in the studied group. In 3 patients (4.5%), 
whose node areas were irradiated, asymptomatic 
ﬁ brosis was observed in the apex of the lung and 
one patient (1.5%) developed effort dyspnoea as 
a symptom of Level 2 lung ﬁ brosis.
Soft tissue necrosis is a rarely described compli-
cation. Meric et al. observed Level 2 necrosis of 
the soft tissues of the breast in one out of 249 pa-
tients [15]. Wazer indicated soft tissue necrosis in 
2% of patients [16]. In the present study, necrosis 
of the soft tissues in the boost area was observed 
in one patient (1.5%). It occurred in an area of 
a long standing scar tissue (from lymphadenec-
tomy) which was proving difﬁ cult to heal.
The risk of post-radiation damage to the brachial 
plexus after post-surgical radiotherapy increases 
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relative to the extent of axillary lymphadenectomy, 
increasing fractional dose and the use of cytostatic 
drugs. At present, it is a rare complication [21–23]. 
The total dose of radiotherapy is extremely rele-
vant. It is supposed that an increased risk of plex-
opathy arises when the biological equivalent of the 
total dose applied to brachial plexus is higher than 
57Gy at fractional dose of 2Gy. The risk of post-ra-
diation complications in the peripheral nervous 
system decreases as the use of three dimensional 
radiotherapy planning, after conservative surgical 
treatment of breast carcinoma, and estimations of 
the applied dose to the brachial plexus are more 
and more widely used [23]. There are few reports 
concerning the occurrence of post-radiation inju-
ries of the brachial plexus in patients after conserv-
ative treatment. Pierce et al. observed medium de-
gree post-radiation plexopathy in 20 out of 1117 
(1.8%) patients who were conservatively treated 
and whose supraclavicular – axillary lymph nodes 
were irradiated with a fractional dose of 2Gy up 
to a total of 50Gy [24]. Chua et al. reported tem-
porary neuropathy of the brachial plexus in 5 out 
of 380 patients (1%) [20].
No cases of signiﬁ cant injury to the brachial plex-
us were observed in the present study. Subjective 
symptoms were observed in two patients and did 
not bring about any considerable decrease in pa-
tients’ standard of living after treatment.
Lymphatic swelling of the arm was the most fre-
quent undesirable symptom in the group of pa-
tients used in the study.
Larson et al. examined the risk of lymphatic swell-
ing of the arm. The main risk factor, for the oc-
currence of swelling, is the extent of the removal 
of axillary lymph nodes. After irradiation of the 
axillary area after full lymphadenectomy of the 
axilla, the 6-year risk of swelling is 36%, which 
is signiﬁ cantly higher than the 6% risk observed 
in patients after removal of only the lower layer 
of the axilla and irradiation of the axillary area 
(P=0.0002). Information about the extent of axil-
lary surgery is very important for radiotherapists. 
After limited lymphadenectomy, irradiation of the 
armpit may be required to secure local control, 
especially when metastases to the lymph nodes 
is observed. The authors suggested that radio-
therapy does not signiﬁ cantly increase the risk of 
swelling in such cases. However, after removal of 
a large part of the axilla, from the area of axillary 
vein, additional irradiation to the area does not 
improve local control and signiﬁ cantly increases 
the risk of swelling. The authors indicated that the 
probability of lymphatic swelling is related more 
to the extent of lymphadenectomy than to the 
number of removed lymph nodes [25].
Pezner et al. observed a more frequent occur-
rence of swelling in patients over 60 years of age 
than in younger patients (P<0.02). In total, swell-
ing was observed in 14% of patients. Owing to low 
numbers of tested patients, no statistically relevant 
occurrences of swelling were observed after the 
use of chemotherapy or radiotherapy [26].
In Meek’s study, the frequency of lymphatic swell-
ing after surgical conservative treatment without 
radiotherapy was 7%, and after irradiation of the 
breast only, the frequency was 10% [27].
Tengrup et al. analysed the occurrence of lym-
phatic swellings of the upper limb after conserv-
ative treatment. The complete group amounted 
to 110 patients, 75 of whom were after breast ir-
radiation and after tumourectomy, while 35 were 
not irradiated. The observation period lasted 
for 5 years, during which lymphatic swelling oc-
curred in 21 patients (19%). Swelling was twice 
as frequent in the group of irradiated patients as 
in the group without irradiation therapy (22% 
and 12%, respectively). Although breast irradi-
ation after conservative treatment does not re-
quire irradiation of the axilla, the lymph nodes 
of the lower level of the axilla are usually within 
the area to be irradiated. Swelling occurred in 
two or three patients within the ﬁ rst two years of 
observation [28].
The combination of axillary lymphadenectomy 
with irradiation of the supraclavicular – axillary 
area causes signiﬁ cantly more frequent swelling 
of the arm in comparison to the group without 
irradiation. Swelling was observed in 9.5% of pa-
tients after axillary surgery, as compared to 6.1% 
of patients treated with irradiation of the supra-
clavicular – axillary area and in 31% of patients 
after axillary lymphadenectomy in combination 
with irradiation of the area [20]. Research con-
ducted in Norway showed that irradiation of the 
axilla and supraclavicular area after axillary sur-
gery results in a 3.5 fold increase in the risk of ax-
illary swelling as compared to the group without 
irradiation. The authors were of the opinion that 
the increased risk of this complication indicates 
that less invasive methods for the treatment of 
the axillary area should be applied [29].
In the group assessed in the present study, lym-
phatic swellings of the upper limb were observed 
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in 15 patients (22%), after an average of 16 
months had elapsed from the end of radiother-
apy (ranging from immediately after the end of 
the treatment to 2 years after its completion). In 
5 patients the difference in diameter was 2–3cm, 
in 9 patients 3–5cm and in one patient the dif-
ference was 7cm. The patients had lymph nodes 
removed from three levels of the axilla. An as-
sessment of the frequency of swelling of the arm 
after radical axillary lymphadenectomy (remov-
al of lymph nodes from three layers of the axil-
la) indicated no signiﬁ cant intensiﬁ cation of the 
complication). As the majority of the patients 
(80%) with swelling underwent rehabilitation 
(including hand or pneumatic lymph drainage, 
physical exercise and positioning), the swelling 
did not intensify and, at the ﬁ nal control visit, 
was observed in 12 patients, (18%). Seven pa-
tients with swellings underwent axillary irradi-
ation. A relationship, close to being statistical-
ly signiﬁ cant (P=0.069), was found between the 
occurrence of lymphatic swelling and irradiation 
of lymph node areas.
CONCLUSIONS
The risk of late post-radiation complications after 
conservative breast carcinoma treatment is gen-
erally low and justiﬁ es the use of radiotherapy 
as a supplement to surgical treatment. This con-
ﬁ rms the positive effects of conservative breast 
treatment. However, in clinical situations when 
irradiation of lymph node areas is necessary, the 
risk of lymphatic swelling in the ipsilateral upper 
limb may increase by 2 to 3 times. In such cases, 
proper rehabilitation, to counter swelling, is ex-
tremely important.
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